224 related articles for article (PubMed ID: 30280193)
21. Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review).
Zhang X; Zeng W; Zhang Y; Yu Q; Zeng M; Gan J; Zhang W; Jiang X; Li H
Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35419616
[TBL] [Abstract][Full Text] [Related]
22. GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.
Tang T; Gong T; Jiang W; Zhou R
Trends Pharmacol Sci; 2018 Sep; 39(9):798-811. PubMed ID: 30054020
[TBL] [Abstract][Full Text] [Related]
23. ALK is required for NLRP3 inflammasome activation in macrophages.
Zhang B; Wei W; Qiu J
Biochem Biophys Res Commun; 2018 Jun; 501(1):246-252. PubMed ID: 29723525
[TBL] [Abstract][Full Text] [Related]
24. Initiation and perpetuation of NLRP3 inflammasome activation and assembly.
Elliott EI; Sutterwala FS
Immunol Rev; 2015 May; 265(1):35-52. PubMed ID: 25879282
[TBL] [Abstract][Full Text] [Related]
25. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming.
Liu X; Zhang X; Ding Y; Zhou W; Tao L; Lu P; Wang Y; Hu R
Antioxid Redox Signal; 2017 Jan; 26(1):28-43. PubMed ID: 27308893
[TBL] [Abstract][Full Text] [Related]
26. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.
Liu D; Zeng X; Li X; Mehta JL; Wang X
Basic Res Cardiol; 2018 Jan; 113(1):5. PubMed ID: 29224086
[TBL] [Abstract][Full Text] [Related]
27. Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome.
Zhang S; Jiang L; Che F; Lu Y; Xie Z; Wang H
Biochem Biophys Res Commun; 2017 Nov; 493(1):821-826. PubMed ID: 28888980
[TBL] [Abstract][Full Text] [Related]
28. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
29. [Regulation of the NLRP3 inflammasome].
Groslambert M; Py BF
Med Sci (Paris); 2018 Jan; 34(1):47-53. PubMed ID: 29384096
[TBL] [Abstract][Full Text] [Related]
30. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
31. Hemin Induces the Activation of NLRP3 Inflammasome in N9 Microglial Cells.
Tan Y; Tan SW; Fan BY; Li L; Zhou YG
Iran J Immunol; 2018 Jun; 15(2):122-132. PubMed ID: 29947341
[TBL] [Abstract][Full Text] [Related]
32. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
[TBL] [Abstract][Full Text] [Related]
33. NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review.
Luo Y; Reis C; Chen S
Curr Neuropharmacol; 2019; 17(7):582-589. PubMed ID: 30592254
[TBL] [Abstract][Full Text] [Related]
34. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
36. Plasticizer DBP Activates NLRP3 Inflammasome through the P2X7 Receptor in HepG2 and L02 Cells.
Ni J; Zhang Z; Luo X; Xiao L; Wang N
J Biochem Mol Toxicol; 2016 Apr; 30(4):178-85. PubMed ID: 26586371
[TBL] [Abstract][Full Text] [Related]
37. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.
Abderrazak A; Syrovets T; Couchie D; El Hadri K; Friguet B; Simmet T; Rouis M
Redox Biol; 2015; 4():296-307. PubMed ID: 25625584
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological Effects and Mechanisms of Chinese Medicines Modulating NLRP3 Inflammasomes in Ischemic Cardio/Cerebral Vascular Disease.
Li Y; Liu Y; Yan X; Liu Q; Zhao YH; Wang DW
Am J Chin Med; 2018; 46(8):1727-1741. PubMed ID: 30525898
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
[TBL] [Abstract][Full Text] [Related]
40. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.
Jiang D; Chen S; Sun R; Zhang X; Wang D
Cancer Lett; 2018 Apr; 419():8-19. PubMed ID: 29339210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
